This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Chinese Academy of Sciences. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Linqian Yu: Innovator in Pharmaceutical Chemistry
Introduction
Linqian Yu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel anti-tumor medications. His innovative work has led to the creation of a unique class of compounds known as rapalogs.
Latest Patents
Linqian Yu holds 1 patent for his invention titled "Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof." This patent focuses on rapalogs of formula I, which include pharmaceutically acceptable salts, pharmaceutical compositions, and preparation methods. The rapalogs developed by Yu exhibit enhanced water solubility and improved pharmacological and pharmacokinetic properties compared to traditional rapamycin. By introducing hydrophilic and polar groups, such as hydroxyl, these compounds show promise as effective anti-tumor medicaments.
Career Highlights
Linqian Yu is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has garnered attention for its potential impact on cancer treatment and pharmaceutical advancements.
Collaborations
Linqian Yu has collaborated with notable colleagues, including Jianping Zuo and Yangming Zhang. Their combined expertise contributes to the innovative research being conducted at the Chinese Academy of Sciences.
Conclusion
Linqian Yu's contributions to pharmaceutical chemistry, particularly through his patented rapalogs, highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in anti-tumor therapies.